Taken together, these results suggest that MASTL overexpression correlates with deregulation of desmosomes, actin regulatory proteins, disruption to PI3K/AKT/mTOR signalling and an increase in DNA damage signalling across patient tumour samples, breast cancer cell lines and our MCF10A model system. This evidence concerns the gene MASTL and neoplasm.